This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Understand which index funds fit a retirement strategy in 2024, including cost considerations and diversification benefits.
23,806 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
MP Materials is catching attention from large buyers of stock as it moves to boost magnet production and solidify the...
A crisis-focused charity is pivoting to support TSA officers unpaid during a partial government shutdown. The effort ...
When a juggernaut like Fortnite cools its engagement, the ripple effect hits the entire company. This piece digs into...
Bitcoin resumes strength amid a broader risk-off backdrop for gold. The bitcoin resurgence faces a critical test near...
An anonymous investor continues to buy the VanEck Uranium and Nuclear ETF every month, betting on nuclear power's lon...
A six-story glass building in Manhattan's Chinatown sits at the center of a courtroom fight over whether it was a cov...
Investors are watching alarm.com with a focus on how 2026 earnings will unfold. This guide explains the key drivers, ...
Big tech’s heavy AI investments are pinching buyback payouts, reshaping capital allocation as investors weigh dividen...
XRP trades near $1.45 as policy and liquidity headlines drive the 12-month outlook. Analysts map three potential path...
Rithm Capital priced a $500 million offering of senior unsecured notes due 2031, signaling a continued push to streng...
Solana has risen about 4.5% over the past week as the Alpenglow upgrade advances in validator testing, stoking bets o...